American Healthcare REIT tops RNP on Aug. 7

American Healthcare REIT is emerging as the more compelling buy in a sector still split between beneficiaries of higher income demand and losers from persistent rate pressure, even as the broader REIT trade remains supported by the prospect of easier policy later this year.
The main investment case is not that REITs are suddenly cheap in a vacuum, but that the earnings power of property owners is being repriced against a still-elevated interest-rate backdrop. The 10-year Treasury yield is around 4.6%, and the federal funds rate is still 3.63%, levels that keep cap rates and financing costs uncomfortably high for many property portfolios. That matters because REIT valuations are highly sensitive to the spread between property cash yields and risk-free rates: when that spread is tight, high-leverage landlords and slower-growth funds struggle to justify premium multiples.

Against that backdrop, American Healthcare REIT, or AHR, has been the stronger momentum name. Its shares closed at $56.74 on Aug. 7, near the top of a recent range and well above both its 50-day moving average of $52.01 and 200-day moving average of $49.39. The stock has recovered sharply from a June pullback, and the rebound has been accompanied by renewed buying interest after the company’s second-quarter filing. By contrast, Cohen & Steers REIT and Preferred and Income Fund, RNP, has been flat around $20.61, barely above its 50-day average and only fractionally ahead of its 200-day average, suggesting limited conviction in a vehicle whose appeal depends on income stability more than growth.
That is why AHR looks like the better REIT to buy and RNP the one to sell. Healthcare property can offer a more resilient operating backdrop than office-heavy or rate-sensitive income funds because demand is tied to aging demographics and post-acute care utilization rather than cyclical lease renewals. AHR’s technical setup also looks healthier: its RSI reading was back near 50.4 on Aug. 7 after cooling from overbought levels above 90 in early July, while its MACD remained positive, indicating the stock has digested gains without breaking trend. RNP’s RSI was only 51.4, but its price action shows little upward follow-through and the fund remains pinned near its long-term average.
The broader sector picture still matters for both names. Bloomberg-style sector gauges are telling a mixed story: commercial REIT sentiment on Adalytica is neutral, while U.S. Treasury bond trade signals show extreme greed, underscoring how aggressively investors have been positioning for lower rates. That combination supports income assets in the short term, but it also raises the bar for REITs with weak growth or leveraged balance sheets. If yields stay elevated, funds such as RNP that mainly package yield exposure may struggle to outperform. If rates begin to fall, the whole REIT complex could rerate, but stronger operators like AHR should benefit first because they have a clearer route to cash-flow growth.
The near-term catalyst is whether the bond market’s latest positioning translates into an actual easing cycle. If the 10-year slips meaningfully below 4.5% and the Fed moves closer to cutting, REIT multiples could expand. If not, investors are likely to keep favoring companies with visible operating leverage and sector-specific demand drivers over broad income wrappers.
| Entity | Gains | Losses |
|---|---|---|
| American Healthcare REIT (AHR) | ▲Rate relief, healthcare demand | ▼Higher-for-longer yields |
| Cohen & Steers REIT and Preferred and Income Fund (RNP) | ▲Falling rates | ▼Flat price momentum |
| REIT buyers | ▲Stronger cash-flow names | ▼Yield-only vehicles |
| Treasury sellers | ▲Higher yields | ▼REIT valuations |